FDA approves software update for faulty defibrillator

October 2nd, 2008 by Kurt Niland

The U.S. Food and Drug Administration (FDA) approved a software update from Medtronic that will help detect fractures in the company’s Sprint Fidelis cardiac defibrillator lead. The software will alert both patients and physicians of a possible fracture in the lead. Earlier intervention in the event of such a fracture will help patients avert the serious complications that can arise.

The new software update, known as the Lead Integrity Alert, will sound an audible alert should it detect signals that indicate a fracture in the lead. The alert will sound repeatedly every four hours until a doctor can reset the . The software update also revises the device’s original settings so that it has more time to discern a lead fracture from an abnormal heart rhythm. This change will likely reduce the number of times the inappropriately shocks the patient.

As we have reported earlier, a Texas man filed a lawsuit against , claiming that his cardioverter containing a Sprint Fidelis lead gave him several unexpected and unnecessary shocks, causing excruciating pain and emotional stress.

To ensure that the software update fulfills its purpose and protects patients as it was designed to do, will actively monitor the update during actual use.

According to Daniel Schultz, M.D., director of the FDA’s Center for Devices and Radiological Health, Medtronic’s software update “will provide Sprint patients with the reassurance that their is being monitored around the clock. While the software doesn’t fix the fracture itself, it may help identify the fracture earlier, allowing patients to see their physicians sooner.”

Implantable defibrillators deliver a pulse of energy through a thin electronic wire (the lead) whenever it detects a rhythmic abnormality in the heart. The shock sets the heart back into a normal rhythm.

blog comments powered by Disqus

Comments are moderated and generally will be posted if they are on-topic and not abusive.